Literature DB >> 10708952

Functions of mammalian Smad genes as revealed by targeted gene disruption in mice.

M Weinstein1, X Yang, C Deng.   

Abstract

The Smad genes are the intracellular mediators of TGF-beta signals. Targeted mutagenesis in mice has yielded valuable new insights into the functions of this important gene family. These experiments have shown that Smad2 and Smad4 are needed for gastrulation, Smad5 for angiogenesis, and Smad3 for establishment of the mucosal immune response and proper development of the skeleton. In addition, these experiments have shown us the importance of gene dosage in this family, as several of its members yielded haploinsufficiency phenotypes. These include gastrulation and craniofacial defects for Smad2, accelerated wound healing for Smad3, and the incidence of gastric cancer for Smad4. Combinatorial genetics has also revealed functions of Smads in left/right isomerism and liver development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708952     DOI: 10.1016/s1359-6101(99)00028-3

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  49 in total

1.  Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase.

Authors:  Y Zhang; C Chang; D J Gehling; A Hemmati-Brivanlou; R Derynck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  RUNX 3, apoptosis 0: a new gastric tumour suppressor.

Authors:  S F Moss
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

3.  An allelic series of mutations in Smad2 and Smad4 identified in a genotype-based screen of N-ethyl-N- nitrosourea-mutagenized mouse embryonic stem cells.

Authors:  Jay L Vivian; Yijing Chen; Della Yee; Elizabeth Schneider; Terry Magnuson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

4.  Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin.

Authors:  Kathleen C Flanders; Christopher D Major; Alidad Arabshahi; Ekinadese E Aburime; Miya H Okada; Makiko Fujii; Timothy D Blalock; Gregory S Schultz; Anastasia Sowers; Mario A Anzano; James B Mitchell; Angelo Russo; Anita B Roberts
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

5.  PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells.

Authors:  Yueli Shi; Xinyu Wang; Zhiyong Xu; Ying He; Chunyi Guo; Lingjuan He; Caijuan Huan; Changhong Cai; Jiaqi Huang; Jie Zhang; Yiqing Li; Chunlai Zeng; Xue Zhang; Linrun Wang; Yuehai Ke; Hongqiang Cheng
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

6.  TGF-beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta-spectrin, ELF.

Authors:  Sang Soo Kim; Kirti Shetty; Varalakshmi Katuri; Krit Kitisin; Hye Jung Baek; Yi Tang; Blair Marshall; Lynt Johnson; Bibhuti Mishra; Lopa Mishra
Journal:  Biochem Biophys Res Commun       Date:  2006-04-19       Impact factor: 3.575

Review 7.  Controlled protein delivery in the generation of microvascular networks.

Authors:  Jillian W Andrejecsk; William G Chang; Jordan S Pober; W Mark Saltzman
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

Review 8.  Cancer stem cells and hepatocellular carcinoma.

Authors:  Zhixing Yao; Lopa Mishra
Journal:  Cancer Biol Ther       Date:  2009-09       Impact factor: 4.742

9.  Smad3 knock-out mice as a useful model to study intestinal fibrogenesis.

Authors:  Giuliana Zanninelli; Antonella Vetuschi; Roberta Sferra; Angela D'Angelo; Amato Fratticci; Maria Adelaide Continenza; Maria Chiaramonte; Eugenio Gaudio; Renzo Caprilli; Giovanni Latella
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

10.  Targeted inactivation of p12, CDK2 associating protein 1, leads to early embryonic lethality.

Authors:  Yong Kim; Jim McBride; Lauren Kimlin; Eung-Kwon Pae; Amit Deshpande; David T Wong
Journal:  PLoS One       Date:  2009-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.